Technomark Life Sciences is a renowned investment group specializing in the life science industry, offering strategic planning, venture capital, and product development services since 1987. With a global presence, they provide turn-key solutions for clinical development programs primarily in the US and Europe, as well as other selective regions, through their co-development investment business model.
As long-term investors, Technomark invests and co-funds the clinical development of their portfolio companies in a hands-on manner, focusing on therapeutics biologics, NCE, orphan, med-tech, and diagnostic devices. Their investments range from seed to Series C, covering Phase I-IV clinical trials, with returns on investment including equity, downstream royalties, and milestone payments. Geographically, they operate in the UK, rest of EU, US, Israel, and other regions.
Generated from the website